Related Articles
Identification of favorable subgroups for alternative anti‑androgen therapy in castration‑resistant prostate cancer
The androgen receptor in hormone-refractory prostate cancer: Relevance of different mechanisms of androgen receptor signaling (Review)
Long-term complete response of antiandrogen withdrawal syndrome in a patient with metastatic prostate cancer: A case report
Maintenance monotherapy with Gemcitabine following cisplatin-based primary combination chemotherapy in surgically treated advanced urothelial carcinoma: A matched-pair single institution analysis
The biological basis for the use of an anti-androgen and a 5-α-reductase inhibitor in the treatment of recurrentprostate cancer: Case report and review